The Influence of Indonesia National Health Insurance Program’s PROLANIS to Controlling Patient with Diabetes Mellitus Type 2
Anisa Fitri Nur Heriantoro
2017
Abstract
Diabetes mellitus type 2 is a chronic disease caused by resistance to insulin that is often associated with an unhealthy lifestyle. Diabetes mellitus type 2 has serious disease complications if it’s not controlled from the outset. These complications include coronary heart disease, stroke and others disease. Therefore, it needs appropriate handling and control for people with type 2 diabetes mellitus in order not to suffer from complications. In the National Health Insurance in Indonesia called JKN, there is a chronic disease management program known as PROLANIS, which also manages diabetes mellitus type 2 preventively and promotively. The purpose of this research is to find whether the PROLANIS program in JKN runs effectively in controlling patient with type 2 diabetes mellitus to avoid complications. The method used in this research is literature study by reviewing articles and scientific journals related to the PROLANIS program. The results obtained in several articles and scientific journals say that with the PROLANIS program it can control some of the clinical diagnostic tests of patients’ diabetes mellitus type 2 so that no complications arise and the quality of life increases. But the continuity of some activity isn’t good enough, as caused by low attendance of participants. The conclusion in this research is that the PROLANIS program can control patient with diabetes mellitus type 2 to be better and stable so that the risk to experience complications becomes less, but that there is need of some effort to maintaining membership of PROLANIS to keep it stable.
DownloadPaper Citation
in Harvard Style
Heriantoro A. (2017). The Influence of Indonesia National Health Insurance Program’s PROLANIS to Controlling Patient with Diabetes Mellitus Type 2.In Proceedings of the 4th Annual Meeting of the Indonesian Health Economics Association - Volume 1: INAHEA, ISBN 978-989-758-335-3, pages 123-127. DOI: 10.5220/0007025101230127
in Bibtex Style
@conference{inahea17,
author={Anisa Fitri Nur Heriantoro},
title={The Influence of Indonesia National Health Insurance Program’s PROLANIS to Controlling Patient with Diabetes Mellitus Type 2},
booktitle={Proceedings of the 4th Annual Meeting of the Indonesian Health Economics Association - Volume 1: INAHEA,},
year={2017},
pages={123-127},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0007025101230127},
isbn={978-989-758-335-3},
}
in EndNote Style
TY - CONF
JO - Proceedings of the 4th Annual Meeting of the Indonesian Health Economics Association - Volume 1: INAHEA,
TI - The Influence of Indonesia National Health Insurance Program’s PROLANIS to Controlling Patient with Diabetes Mellitus Type 2
SN - 978-989-758-335-3
AU - Heriantoro A.
PY - 2017
SP - 123
EP - 127
DO - 10.5220/0007025101230127